Creative Planning’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8K | Buy |
+11,852
| New | +$20.8K | ﹤0.01% | 3560 |
|
|
2024
Q1 | – | Sell |
-4,752
| Closed | -$32.7K | – | 2922 |
|
|
2023
Q4 | $32.7K | Hold |
4,752
| – | – | ﹤0.01% | 2657 |
|
|
2023
Q3 | $29.9K | Hold |
4,752
| – | – | ﹤0.01% | 2524 |
|
|
2023
Q2 | $39.4K | Hold |
4,752
| – | – | ﹤0.01% | 2434 |
|
|
2023
Q1 | $20.9K | Sell |
4,752
-100
| -2% | -$440 | ﹤0.01% | 2376 |
|
|
2022
Q4 | $28.6K | Buy |
4,852
+100
| +2% | +$590 | ﹤0.01% | 2269 |
|
|
2022
Q3 | $33K | Buy |
4,752
+99
| +2% | +$687 | ﹤0.01% | 2121 |
|
|
2022
Q2 | $67K | Hold |
4,653
| – | – | ﹤0.01% | 1999 |
|
|
2022
Q1 | $175K | Buy |
+4,653
| New | +$175K | ﹤0.01% | 1913 |
|